Using prediction algorithms, Moskwa et al. found miRNA-182 targeted BRCA1 in breast cancer [91], and overexpression of miRNA-182Its in MDA-MB231 cells was significantly more sensitive to PARPi [91]. Here, BRCA1 is linked to breast carcinoma.